AIMC Topic: Blood Coagulation Factor Inhibitors

Clear Filters Showing 1 to 2 of 2 articles

Prediction of inhibitor development in previously untreated and minimally treated children with severe and moderately severe hemophilia A using a machine-learning network.

Journal of thrombosis and haemostasis : JTH May 27, 2024
BACKGROUND: Prediction of inhibitor development in patients with hemophilia A (HA) remains a challenge.
Humans Machine Learning Biomarkers Reproducibility of Results Risk Factors Male Risk Assessment Infant Severity of Illness Index Time Factors Treatment Outcome Predictive Value of Tests Blood Coagulation Factor Inhibitors Hemophilia A Factor VIII
View on PubMed DOI

Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Blood transfusion = Trasfusione del sangue Nov 14, 2017
Mild haemophilia is defined by factor levels between 0.05 and 0.40 IU/mL and is characterised by traumatic bleeds. Major issues associated with mild haemophilia are that it may not present for many years after birth, and that awareness, even within f...
Humans Guidelines as Topic Blood Coagulation Factor Inhibitors Blood Coagulation Factors Hemophilia A
View on PubMed DOI
Popular Topics
Recent Journals